Global Biopharmaceutical CMO & CRO Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 107

Report ID: 3343

A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
U.S is estimated to have the largest number of biomanufacturing facilities, which in turn, has resulted in the largest share of North America region. Moreover, presence of effective regulatory bodies to monitor the overall biopharmaceutical development process to ensure the product safety and efficacy is driving the regional market of North America.
In 2018, the global Biopharmaceutical CMO & CRO market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biopharmaceutical CMO & CRO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical CMO & CRO development in United States, Europe and China.

The key players covered in this study
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi Biologics

Market segment by Type, the product can be split into
Mammalian
Non-mammalian

Market segment by Application, split into
Contract Manufacturing
Contract Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biopharmaceutical CMO & CRO status, future forecast, growth opportunity, key market and key players.
To present the Biopharmaceutical CMO & CRO development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biopharmaceutical CMO & CRO are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (2014-2025)
1.4.2 Mammalian
1.4.3 Non-mammalian
1.5 Market by Application
1.5.1 Global Biopharmaceutical CMO & CRO Market Share by Application (2014-2025)
1.5.2 Contract Manufacturing
1.5.3 Contract Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biopharmaceutical CMO & CRO Market Size
2.2 Biopharmaceutical CMO & CRO Growth Trends by Regions
2.2.1 Biopharmaceutical CMO & CRO Market Size by Regions (2014-2025)
2.2.2 Biopharmaceutical CMO & CRO Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Biopharmaceutical CMO & CRO Market Size by Manufacturers
3.1.1 Global Biopharmaceutical CMO & CRO Revenue by Manufacturers (2014-2019)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
3.2 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
3.3 Key Players Biopharmaceutical CMO & CRO Product/Solution/Service
3.4 Date of Enter into Biopharmaceutical CMO & CRO Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biopharmaceutical CMO & CRO Market Size by Type (2014-2019)
4.2 Global Biopharmaceutical CMO & CRO Market Size by Application (2014-2019)

5 United States
5.1 United States Biopharmaceutical CMO & CRO Market Size (2014-2019)
5.2 Biopharmaceutical CMO & CRO Key Players in United States
5.3 United States Biopharmaceutical CMO & CRO Market Size by Type
5.4 United States Biopharmaceutical CMO & CRO Market Size by Application

6 Europe
6.1 Europe Biopharmaceutical CMO & CRO Market Size (2014-2019)
6.2 Biopharmaceutical CMO & CRO Key Players in Europe
6.3 Europe Biopharmaceutical CMO & CRO Market Size by Type
6.4 Europe Biopharmaceutical CMO & CRO Market Size by Application

7 China
7.1 China Biopharmaceutical CMO & CRO Market Size (2014-2019)
7.2 Biopharmaceutical CMO & CRO Key Players in China
7.3 China Biopharmaceutical CMO & CRO Market Size by Type
7.4 China Biopharmaceutical CMO & CRO Market Size by Application

8 Japan
8.1 Japan Biopharmaceutical CMO & CRO Market Size (2014-2019)
8.2 Biopharmaceutical CMO & CRO Key Players in Japan
8.3 Japan Biopharmaceutical CMO & CRO Market Size by Type
8.4 Japan Biopharmaceutical CMO & CRO Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biopharmaceutical CMO & CRO Market Size (2014-2019)
9.2 Biopharmaceutical CMO & CRO Key Players in Southeast Asia
9.3 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Type
9.4 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Application

10 India
10.1 India Biopharmaceutical CMO & CRO Market Size (2014-2019)
10.2 Biopharmaceutical CMO & CRO Key Players in India
10.3 India Biopharmaceutical CMO & CRO Market Size by Type
10.4 India Biopharmaceutical CMO & CRO Market Size by Application

11 Central & South America
11.1 Central & South America Biopharmaceutical CMO & CRO Market Size (2014-2019)
11.2 Biopharmaceutical CMO & CRO Key Players in Central & South America
11.3 Central & South America Biopharmaceutical CMO & CRO Market Size by Type
11.4 Central & South America Biopharmaceutical CMO & CRO Market Size by Application

12 International Players Profiles
12.1 Lonza
12.1.1 Lonza Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biopharmaceutical CMO & CRO Introduction
12.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.1.5 Lonza Recent Development
12.2 Boehringer Ingelheim GmbH
12.2.1 Boehringer Ingelheim GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biopharmaceutical CMO & CRO Introduction
12.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.2.5 Boehringer Ingelheim GmbH Recent Development
12.3 Rentschler Biotechnologie GmbH
12.3.1 Rentschler Biotechnologie GmbH Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biopharmaceutical CMO & CRO Introduction
12.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.3.5 Rentschler Biotechnologie GmbH Recent Development
12.4 Inno Biologics Sdn Bhd
12.4.1 Inno Biologics Sdn Bhd Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biopharmaceutical CMO & CRO Introduction
12.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.4.5 Inno Biologics Sdn Bhd Recent Development
12.5 JRS Pharma
12.5.1 JRS Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biopharmaceutical CMO & CRO Introduction
12.5.4 JRS Pharma Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.5.5 JRS Pharma Recent Development
12.6 BIOMEVA GmbH
12.6.1 BIOMEVA GmbH Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biopharmaceutical CMO & CRO Introduction
12.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.6.5 BIOMEVA GmbH Recent Development
12.7 ProBioGen
12.7.1 ProBioGen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biopharmaceutical CMO & CRO Introduction
12.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.7.5 ProBioGen Recent Development
12.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
12.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biopharmaceutical CMO & CRO Introduction
12.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
12.9 TOYOBO CO., LTD
12.9.1 TOYOBO CO., LTD Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biopharmaceutical CMO & CRO Introduction
12.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.9.5 TOYOBO CO., LTD Recent Development
12.10 Samsung BioLogics
12.10.1 Samsung BioLogics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biopharmaceutical CMO & CRO Introduction
12.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2014-2019)
12.10.5 Samsung BioLogics Recent Development
12.11 Patheon
12.12 CMC Biologics
12.13 Binex Co., Ltd.
12.14 AbbVie Inc.
12.15 WuXi Biologics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details